Key features and details
- Mouse monoclonal [TS9] to CD9
- Suitable for: WB, IP, Flow Cyt
- Reacts with: Human
- Isotype: IgG1
Product nameAnti-CD9 antibody [TS9]
See all CD9 primary antibodies
DescriptionMouse monoclonal [TS9] to CD9
Tested applicationsSuitable for: WB, IP, Flow Cytmore details
Species reactivityReacts with: Human
HeLa cell line
This product was changed from ascites to tissue culture supernatant on 19th June 2019. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
Storage bufferConstituent: PBS
sterile-filtered through 0.22 µmmEndotoxin, Carrier and preservative free
Concentration information loading...
PurityTissue culture supernatant
Our Abpromise guarantee covers the use of ab58989 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use at an assay dependent concentration. Predicted molecular weight: 24 kDa.|
|IP||Use at an assay dependent concentration.|
|Flow Cyt||Use at an assay dependent concentration.
ab170190 - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.
FunctionInvolved in platelet activation and aggregation. Regulates paranodal junction formation. Involved in cell adhesion, cell motility and tumor metastasis. Required for sperm-egg fusion.
Tissue specificityExpressed by a variety of hematopoietic and epithelial cells.
Sequence similaritiesBelongs to the tetraspanin (TM4SF) family.
modificationsProtein exists in three forms with molecular masses between 22 and 27 kDa, and is known to carry covalently linked fatty acids.
- Information by UniProt
- Tetraspanin 29 antibody
- 5H9 antibody
- 5H9 antigen antibody
ab58989 has been referenced in 3 publications.
- Theodoraki MN et al. Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT. Oncoimmunology 8:1593805 (2019). PubMed: 31143513
- Battisti F et al. Tumor-Derived Microvesicles Modulate Antigen Cross-ProcessingviaReactive Oxygen Species-Mediated Alkalinization of Phagosomal Compartment in Dendritic Cells. Front Immunol 8:1179 (2017). PubMed: 28993771
- Harris HJ et al. Claudin association with CD81 defines hepatitis C virus entry. J Biol Chem 285:21092-102 (2010). Human . PubMed: 20375010